Skip to content

Rifaximin Impurity 3

Rifaximin Impurity 3

Product Description
CAT No.
ALN-R027016
CAS No.
NA
Mol. F.
C43H49N3O11
Mol. Wt.
783.9
Stock
Please Inquire
RFQ
Chemical Name : (12S,32Z,4R,5R,6S,7R,8R,9S,10R,11S,12E)-15,16,5,7-tetrahydroxy-11-methoxy-12,14,111,33,4,6,8,10-octamethyl-11-oxo-11,12-dihydro-32H-14-oxa-2-aza-1(7,2)-furo[2”,3”:7′,8′]naphtho[1′,2′:4,5]imidazo[1,2-a]pyridina-3(2,6)-pyranacyclotetradecaphan-12-en-9-yl acetate
Smiles : CC1=CC=C2O/C1=N\C3=C(O)C(C(O)=C4C)=C(C5=C3N6C(C=C(C)C=C6)=N5)C7=C4O[C@](C7=O)(C)O/C=C/[C@H](OC)[C@@H](C)[C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@H]2C

Structural elucidation of the Rifaximin Ph. Eur. Impurity H

Riccardo Stradi, Donatella Nava, Marino Nebuloni, Barbara Pastura, ElenaPininJournal of Pharmaceutical and Biomedical Analysis Volume 51, Issue 4, 11 March 2010, Pages 858-865

Structure Elucidation of Two Unknown Oxydic Degradation Impurities of Rifaximin

chao liu, chang-qin hu\xa0 and shao-hong jin – Asian Journal of Chemistry; Vol. 23, No. 7 (2011), 3252-3256

Development and validation of rp-hplc method for the estimation of rifaximin in bulk and in tablet dosage form

T.sudha, P.V.hemalatha, V.R.ravikumar,r.jothi, M.radhakrishnan – Asian Journal of Pharmaceutical and Clinical Research Vol.2 Issue 4, October-December 2009

Request For Quotation

Related Products